Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf-" ; - % ;
- -3 "
* :
>$ : ? ', >!+- , , , , , ; & - , , ,$ ; : , , ; " : , , .
$ : " & : "( " &, 3 & " & , !- @% , , & ); " ;" , " " ( " % , , , , )
" : , 3
" :
1.! "- & "
2.6
3.6 & " "
5 :
1.# ;
2.7 ;
3.;
4.& .
|
|
: |
|
|
&% : |
1.H " # ( " , % V – 3 ).
2.! % & , $# " " % & (3 )
:
1. |
& & , |
" |
&$ , & % |
& % ;
2.% " & ;
3." , , ;
4.7 , .
:
1.;
2.1 ;
3.- ;
4.;
5.& " , ;
6.;
7.3 ;
8.# S-T;
9.;.
" 8 ,-
1.+ " ( , ): - ; - " ;
- " -
2.> .
@ " 5 , "& " .
" & :
1.7 ;
2.7 ;
3.( );
4.H)B $ ;
5.B & ;
6.# (6 );
7.– ;
8.!- ;
9.;
10.# ;
11.;
12.3- , ;
13.B ;
14.# " ;
15." % ;
16.? " & ;
17.;
18.?J;;
19.?!;;
20..
" & & :
1.H)B ;
2.7 ;
3.! " 7 G ;
4.;
5.# ;
6." & ;
7." , , ;
8.;
9." ;
10.;
11.$;
12.& ;
13.6- .
+
1.& % .
2.& – + '!: 60-100 ,2,0 . , 2-2,5-3 / / ., 2-3 / / .,30-40 / / ., 10-20 / / ., 5 / / .
3.$ – 0,5-1,0 / / 2-3 $#
10. */ 250 , 500 .; 750 V;
11.*/ 250 , 500 , 1 000 , , V ;
12.* @ 62,5 , 250 .; 0,025% 1 .;
13.*_ 40 , .; 20 /2 , .;
14.*! 25 ; 50 .;
15.*? 200 , 800 .;
16.* 40 , ;
17.*' 40 , 80 .;
18.*7 2,5 , 10 .; 1,25 /1 .;
19.*$ 5%, 10% 400 , 500 ; 40% 5 , 10 .;
20.*@ "& 200 , V ; 40 / 10%, 20% ;
21.*? 50 , 100 , 500 .; 5%, 10% 2 , 5 .
" & & :
1.B 25 ;
2.+ 250 , .;
3.*B 200 , 400 .;
4.+ 500 ;
5.( ) 200 ;
6.*! 1,5 >@, 375 >@ , 750 >@ ; 1,5 >@;
7.* 250 , 500 .;
8. */ 1000 , V ;
9.*/ 250 , 500 , ., .; 125 , 250 /5 , ;
10.50 .;
11./ 12,5% 10000 ;
14.*_ 50 , 150 .; 100 / ;
15.*? 50 , 100 .;
16.*? 200 ., 150 /3 .;
17.*J 10% 2 V ;
18.50 .;
19.1,0 .;
20.75-100 ;
,- ! :
H & " # , " " &" & (7 , , 7 ) ,$ 3 " .
+ "- " , % % - B;
/ , & :
1.Rheumatic Carditis: A Reappraisal R Juneja, R Tandon. Department of Cardiology, All India Institute of Medical Sciences and Sitaram Bhartia Institute of Science and Research, New Delhi. www.g-i-n.net
2.Does rheumatic myocarditis really exists? Systematic study with echocardiography and cardiac troponin I blood levels. November 2002. kamblock@mail.pf
3.G 3 ! , % . G .. @ " . 19.09.2001. www.ncbi.nlm.nih.gov/entrez/query.fcgi
4.+ '. ., !.?. 6 " . B . ?.J. 6 + 6) _. www.pdateam.ru/
5.! " . II. " . www.mail.ru
* – , # (% % )
" :
1.% & ( , , , );
2.% (3 , " , " " " &);
2) " % "
5 :
1.# ;
2.# " .
|
: |
? & : |
|
' |
" ( ). ! |
$ " 1—4 . ( ) . |
|
6 " , " « » ( ); "
& |
|
3 |
( , |
|
|
||||||
); % " |
— 1-3 / . |
|
|
||||||||
[ , , # , % . |
|
|
|
|
|
||||||
? (% $ &). |
|
|
|
|
|
|
|
||||
J % " " " & (" # " ) — 3, |
|||||||||||
3, , . |
|
|
|
|
|
|
|||||
; , , & ( " 3 , [ ). |
|
|
|||||||||
, , & % , & ( +). |
|
|
|
|
|||||||
J ( & " , ). |
|
||||||||||
" , # . |
|
|
|
|
|||||||
J : |
|
|
|
|
|
|
|
|
|||
H |
|
" |
: |
! 7 20-30 |
/", |
||||||
|
|
|
?; |
(- -, |
|
, |
|||||
), |
|
|
"[ |
!)- |
|
% |
# |
||||
. |
|
|
|
|
|
|
|
|
|
|
|
! % !_, . |
|
|
|
|
|||||||
# " : |
& " ; 3 — " |
|
|||||||||
|
$# [ |
; (" # ). |
|
|
|
|
|||||
& ( 3 / ).
H & V[ " " , + — ( 500 / )( 100 / ).
, — $# " . + " : ! <, , , % — # , & , % ,- 2- ; % [ ( "[ ).
! & :
< $# " & " , [ : &" , " & , $# . @ +$# " :
3 . B & " " " . 7- .
7 " , %IgG, !), % — !1q !4.
H)B " : , " ( +), 3 & % .
7 ? % " % .
" & :
1.# (6 );
2.# " , " ;
3., , ;
4.& , ;
5.;
6.$;
7.# , ;
8._ (!3, !4);
9.B ?, G, 6;
10.!- ;
11.1 ( , , , ?L;', . & , );
12.?!;, ?J;;
13.? " ) ;
14.;
15." , " ;
16.H)B $ ;
17.& : ;
18., K ;
19.;
20.; ;
21.(?!J-);
22.;
23., ;
24.LE – , ?+?, ANCA, cANCA;
25.B - .
" & & :
1.6 ;
2.B_?- ;
3.& ;
4.< " ;
5. < |
" ., - $., 3 . ; |
||||||
6. . |
|
|
|||||
+ |
: |
|
|
|
|
|
|
+ " : |
|
|
|
||||
% |
& , |
|
& " 1-3 ., |
" |
[ |
||
?@ — % . |
|
|
|||||
" |
|
|
1-2 / ., % ( V[ |
" |
% |
||
"$ "[ |
# & + 300 ), |
0,5-1 / / . |
|||||
B$"$ |
, , # & , |
, |
|||||
" , . |
|
|
|
|
|
|
|
6 " : |
|
|
|
|
|||
? & " |
|
" " |
|||||
&$ " 3 . |
|
|
|||||
+ ( , ?;) —
0,5—1 >@ 6 / 10 |
, 750—500 |
|
2 10 ( 50 / / [ 10 ). |
||
, ( |
" |
& |
) — 500-750 |
& 2 5-7 , |
|
500 2 7 ( 40 / / 2 [ 7 ).
†- "$ J! : 3 250 4 10 , 250-500 1 4 , 150 27 .
! " " :
? — ?_ ( , 3 2,5-5-10 / .), &( – 40 / .), .
[ % " " — ( , ,
& ). |
|
|
B |
$ |
+ &$; 3 & |
J! |
& . |
|
" :
& % , $ % , & ?@.& :
, — . @ & :
+ " 3 : $ % ( % , , " ), ; " ( " , ) ( , "– 3 & ), $ " 5 (
– % & ?@, , " , %" !_ – K ).
> " & 3 , &3$ (3 & ), " " 6.
:
' 85-90% " . 3 " + 95%" $ " 3-6 , " +$ & 60% & .
|
5-10% 20 % |
" |
" G + |
$# .
J & & % — , " " &$, % +.
" & :
1. |
*< 500 000 >@, 1 000 000 >@ V ; |
2. |
*/ 250 , 500 , ; 125 , 250 /5 ; |
3.*7 250 , 500 , .;
4.*? 125 , 500 ; 250 .;
5.*! 1,5 >@, 375 >@, 750 >@ ;1,5 >@;
6.*_ 2,5 , 10 , .;
7.*7 2,5 , 10 , .;
8.*! 25 ; 50 .;
" & & :
1.* ? 500 , 1000 ; 250 ; 500 .;
2.*? 5 , 10 , . ;
3.*? 25 , .
/ , & :
1.K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002 Feb;39(2 Suppl 1):S1-246.
2.Haematuria EBM Guidelines 26.8.2004
3.Glomerulonephritis CLINICAL PRACTICE GUIDELINES MOH Clinical Practice Guidelines 6/2001 http://www.gov.sg/moh/pub/cpg/cpg.htm
4.Hematuria. Philadelphia (PA): Intracorp; 2005. Various p.
5.Singapore Ministry of Health. Glomerulonephritis. Singapore: Singapore Ministry of Health; 2001 Oct. 132 p
6.Glomerulonephritis EBM Guidelines 19.6.2004
7." + " " : B.+.@ , M.J. K " – 6.: 7 ;? -6>@, 2004. – 1184 .: . ( «@ & 6 »)
* – , # (% % )